The Valley Desk

NCT05519475 · Interventional trial

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Overall registry status Active not recruiting

Phase 2

Conditions Metabolic Dysfunction-Associated SteatoHepatitis (MASH)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov